Covering NGS, array and FISH probe technologies and cancer, constitutional and rare disease applications.
Identifying a broader range of genetic syndromes using exon-focussed array designs
This workshop outlines the development of the new CytoSure Constitutional v3 arrays and how Emory University School of Medicine complements its NGS workflows using the CytoSure™ Medical Research Exome array.
Enhanced bait design strategies that deliver more reliable NGS panel assays
Hear Chris Mattocks, Senior Clinical Research Scientist at the National Genetics Reference Laboratory (Wessex), Salisbury, UK, discuss the advantages of hybridisation enrichment and the importance of optimal bait design.
SureSeq™ Interpret Software demo
Watch this demonstration video to discover how OGT's powerful SureSeq Solid Tumour Panel and complimentary SureSeq Interpret Software can make the analysis of solid tumour samples simple.
CytoSure Interpret Software Tutorial - Getting Started
Getting started with CytoSure Interpret Software is easy. Find out how with this video tutorial.
CytoSure Interpret Software Tutorial - Sample Tracking
Make microarray sample mix-up a thing of the past with CytoSure Sample Tracking Spike-ins. See how they work in our short video.
ASHG Workshop 2014
Held at the American Society of Human Genetics (ASHG), this workshop featured presentations from Professor Madhuri Hegde, Professor of Human Genetics, Emory University and Dr Mike Evans, CEO at OGT.
ASHG Workshop 2013
Held at the American Society for Human Genetics in Boston, this workshop featured presentations from Professor Madhuri Hegde, Professor of Human Genetics, Emory University and Mike Evans, CEO at OGT.
BSGM Workshop 2013
Held at the British Society for Genetic Medicine in Liverpool, this workshop featured presentations from Professor Bass Hassan, Professor of Medical Oncology, University of Oxford and James Clough, Executive Vice-President of Commercial at OGT.
ESHG Workshop 2012
Held at the ESHG 2012 conference in Nuremberg, this workshop featured presentations from international experts in array and sequencing-based cancer and rare disease research, including: